Skip to content

Faculty profile

David Kelvin

Back to faculty
ResearcherMicrobiology and ImmunologyDalhousie University

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Dalhousie University directory, so their courses may be missing. Find their university profile.

Latest papers

  • Remdesivir triphosphate as a potential repurposed drug against the emerging Bundibugyo Ebolavirus 2026.

    The Journal of infection · 2026

  • Unleashing the immune arsenal: development of broad spectrum multiepitope bluetongue vaccine targeting conserved T cell epitopes of structural proteins.

    BMC genomics · 2026

  • Inter-epidemic seroprevalence of Rift Valley fever virus and associated risk factors in humans in Eastern Rwanda.

    PLoS neglected tropical diseases · 2025

All 14 publications

Latest funding

  • Case presentation of patients hospitalized with mpox (subclade Ib/2023sh) including children, adolescents, and adults in South Kivu, Democratic Republic of the Congo: an observational cohort study

    CIHR · 2025 · Supervisor

    $2,157
  • Canada Research Chair - Tier 1

    CIHR · 2024 · Nominated PI

    $1,400,000
  • Strengthening global and regional health security through surveillance of emerging Poxviruses in humans, domestic and peri-domestic animals, and wildlife

    CIHR · 2023 · Nominated PI

    $500,000
All 8 grants and awards
Something wrong or missing on this profile? Suggest a correction